@prefix this: . @prefix sub: . @prefix np: . @prefix pav: . @prefix rdf: . @prefix infores: . @prefix xsd: . @prefix umls: . @prefix orcid: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix unii: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { umls:C0406317 a biolink:DiseaseOrPhenotypicFeature; rdfs:label "plaque psoriasis"; biolink:category biolink:DiseaseOrPhenotypicFeature . unii:FYS6T7F842 a biolink:ChemicalEntity; rdfs:label "Adalimumab"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "rheumatoid arthritis"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "Crohn's disease"; biolink:category biolink:DiseaseOrPhenotypicFeature . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject unii:FYS6T7F842; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_2 rdf:object umls:C0406317; rdf:predicate biolink:treats; rdf:subject unii:FYS6T7F842; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_3 rdf:object ; rdf:predicate biolink:treats; rdf:subject unii:FYS6T7F842; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-11T07:48:16.935632"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627; prov:wasQuotedFrom " Adalimumab is indicated to treat the following conditions: moderately to severely active rheumatoid arthritis in adults. Crohn's disease in patients 6 years of age and older. Moderate to severe chronic plaque psoriasis in adults who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate, as well as those with systemic therapy are less likely to benefit from phototherapy." . biolink: pav:version "2.3.0" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB"; npx:hasSignature "k/GnrG9XHoU8H+BGJEa53WNyJlWjDAhwG+BzV5ovDcj01FBtJTL/bqol4bjQQMa7eBxBNlWEYpO2JIR0/S75PYUGhLuwg7k/42pnnrajWp+4nbFYnzPJvcUtV0JvRy73KyIfU/FUvRiLLQh0p32qwWbqxj+GozPVxcJWAto3puprrZILRTjCzXXqrjEzGnktGD0qprAk6uFgWn2rCudwLJKwv+iO6GpAxSWe8HHlXS2nB1XF1CbTlkDuV/3YuSYKGgK9eHs629KbZbSSITzBzBkwFH8yq2W1rfedNwHPuhyUEMG3FP43BWDhzhR0/Q/xI7D6C6RzKQEP7pxRaLLe2w=="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-11T07:48:16.935632"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627 . }